Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Paxton says the “woke” EHR giant is intentionally making it harder for patients and families to access historical medical data, violating state law. Epic denies the allegation.
Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.
The results were shown in multiple posts on X. A clinical trial to prove the safety and efficacy of Elon Musk's brain implant is ongoing, with 12 people currently using the devices.
The all-cash deal is expected to be finalized in April 2026. With this divestment of its ambulatory labs, Tennessee-based Community Health Systems said it will be better able to focus on its core patient care business.
Researchers have combined three emerging technologies to detect and classify breast cancers found in follow-up imaging of women whose recent screening mammography was deemed normal.
The National Academies of Sciences, Engineering, and Medicine have released a report estimating $100 million will be needed for each of the next 15 years to learn how exposure to low doses of radiation affect human health.
Medical experts testifying in malpractice suits for the defense tend to have higher objective indicators of erudition than peers testifying for the plaintiff. Radiologists buck this pattern.
Comparing six dual-energy CT technologies marketed by three scanner manufacturers, radiology researchers have found all models helpful in determining the chemical composition of kidney stones even at substantially reduced radiation doses.